StoneCalibre Acquires Specialty Detergent and Synthetic Lipid Manufacturer Anatrace From Affymetrix
October 14 2013 - 9:00AM
Marketwired
StoneCalibre Acquires Specialty Detergent and Synthetic Lipid
Manufacturer Anatrace From Affymetrix
Industry: Life Sciences
LOS ANGELES, CA--(Marketwired - Oct 14, 2013) - StoneCalibre
today announced the completion of the acquisition of Anatrace, a
part of Affymetrix, Inc. (NASDAQ: AFFX). Headquartered in Maumee,
Ohio, Anatrace is a highly specialized developer, manufacturer and
global distributor of unique, high purity detergents and synthetic
lipids for use in membrane protein studies.
Established in 1985, Anatrace has built the broadest portfolio
of detergents and lipids available in the marketplace with a core
competency of developing and manufacturing creative solutions for
stabilizing and solubilizing macromolecules.
"Anatrace is a high quality company offering a value-add product
that is mission critical to its customer base," said Brian Wall,
Founder and Chief Executive Officer of StoneCalibre. "We are
confident that as a standalone company, Anatrace will continue to
build on its tradition of collaborating with its global customer
base to help answer critical questions in the advancement of
important studies across multiple scientific fields including
cancer research."
"StoneCalibre has been a great partner for us through this
process," said Frank Witney, Chief Executive Officer of Affymetrix.
"Their corporate carve-out experience and ability to offer speed
and certainty around the sale process were critical factors for us.
We feel that StoneCalibre will provide a great long-term home for
Anatrace and its devoted employee base."
Ben Travis, the newly appointed CEO of Anatrace, expressed his
enthusiasm for partnering with StoneCalibre. "Anatrace's passion
for detergents and lipids, combined with StoneCalibre's strategic
and financial support, will help drive the company to higher levels
of excellence and allow us to capitalize on future growth
opportunities."
Anatrace is StoneCalibre's second acquisition in the last five
months. The terms of the transaction were not disclosed. EMA
Partners acted as the exclusive financial advisor to
Affymetrix.
About StoneCalibre
Headquartered in Century City, CA, StoneCalibre is a privately
funded investment firm specializing in the acquisition of lower
middle market companies. Founded by Brian Wall in 2012,
StoneCalibre is focused on making investments in both special
situations and quality long-term capital investment opportunities.
For more information please visit our website at
www.stonecalibre.com.
About Affymetrix
Affymetrix technologies enable multiplex and simultaneous
analysis of biological systems at the cell, protein, and gene
level, facilitating the rapid translation of bench-top research
into clinical and routine use for human health and wellness.
Affymetrix strives to provide leadership and support, partnering
with customers in pharmaceutical, diagnostic, and biotechnology
companies, as well as leading academic, government, and non-profit
research institutes in their quest for answers toward using biology
for a better world.
More than 2,300 microarray systems have been shipped around the
world and more than 48,000 peer-reviewed papers have been published
citing these technologies. Affymetrix is headquartered in Santa
Clara, California, and has manufacturing facilities in Cleveland,
Ohio, San Diego, Vienna and Singapore. The Company has about 1,100
employees worldwide and maintains sales and distribution operations
across Europe, Asia, and Latin America. For more information about
Affymetrix, please visit www.affymetrix.com.
For more information please contact: Nick Matzke Business
Development StoneCalibre, LLC Phone: (310) 774-0376 Fax: (310)
427-7448 Email Contact
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Jul 2023 to Jul 2024